JSM2023
Back to the program
Topic-Contributed Paper Session

Impact of unplanned interim analyses on Type I error in clinical trials

Tue, Aug 8, 2:00 PM
Olga MarchenkoOrganizerRajeshwari SridharaOrganizerLisa LaVangeChair
Biopharmaceutical Section

3 Presentations

Assessment and Control of the Type 1 Error Rate after Unplanned Interim Analyses
2:05 PM - 2:25 PM
Martin Posch (Medical University of Vienna)
Co-authors: Alexandra Graf (Medical University of Vienna), Franz Koenig (Medical University of Vienna)
Challenges in the interpretation of unplanned analyses in cancer clinical trials
2:25 PM - 2:45 PM
Rajeshwari Sridhara
Unplanned interim analyses: why and how
2:45 PM - 3:05 PM
Olga Marchenko (Bayer)

Discussants

Andrew Raven (Health Canada)
Elizabeth Barksdale (LUNGevity)
↑